113 related articles for article (PubMed ID: 9507986)
1. Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil.
Mohan WS; Chen ZQ; Zhang X; Khalili K; Honjo T; Deeley RG; Tam SP
J Lipid Res; 1998 Feb; 39(2):255-67. PubMed ID: 9507986
[TBL] [Abstract][Full Text] [Related]
2. Protein-DNA interactions at a drug-responsive element of the human apolipoprotein A-I gene.
Zhang X; Chen ZQ; Wang Z; Mohan W; Tam SP
J Biol Chem; 1996 Oct; 271(43):27152-60. PubMed ID: 8900208
[TBL] [Abstract][Full Text] [Related]
3. Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2).
Jin FY; Kamanna VS; Chuang MY; Morgan K; Kashyap ML
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1052-62. PubMed ID: 8696946
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human apolipoprotein A-I gene expression by gramoxone.
Cuthbert C; Wang Z; Zhang X; Tam SP
J Biol Chem; 1997 Jun; 272(23):14954-60. PubMed ID: 9169468
[TBL] [Abstract][Full Text] [Related]
5. Effects of dimethyl sulfoxide on apolipoprotein A-I in the human hepatoma cell line, HepG2.
Tam SP; Zhang X; Cuthbert C; Wang Z; Ellis T
J Lipid Res; 1997 Oct; 38(10):2090-102. PubMed ID: 9374131
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human apolipoprotein A-I gene expression by equine estrogens.
Zhang X; Jiao JJ; Bhavnani BR; Tam SP
J Lipid Res; 2001 Nov; 42(11):1789-800. PubMed ID: 11714848
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts.
Goto D; Okimoto T; Ono M; Shimotsu H; Abe K; Tsujita Y; Kuwano M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2707-12. PubMed ID: 9409246
[TBL] [Abstract][Full Text] [Related]
8. Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3.
Harnish DC; Malik S; Karathanasis SK
J Biol Chem; 1994 Nov; 269(45):28220-6. PubMed ID: 7961760
[TBL] [Abstract][Full Text] [Related]
9. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
[TBL] [Abstract][Full Text] [Related]
10. Effect of chromium on apolipoprotein A-I expression in HepG2 cells.
Haas MJ; Sawaf R; Horani MH; Gobal F; Wong NC; Mooradian AD
Nutrition; 2003 Apr; 19(4):353-7. PubMed ID: 12679171
[TBL] [Abstract][Full Text] [Related]
11. NFY transcription factor binds to regulatory element AIC and transactivates the human apolipoprotein A-I promoter in HEPG2 cells.
Novak EM; Bydlowski SP
Biochem Biophys Res Commun; 1997 Feb; 231(1):140-3. PubMed ID: 9070236
[TBL] [Abstract][Full Text] [Related]
12. SREBP-1 binds to multiple sites and transactivates the human ApoA-II promoter in vitro : SREBP-1 mutants defective in DNA binding or transcriptional activation repress ApoA-II promoter activity.
Pissios P; Kan HY; Nagaoka S; Zannis VI
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1456-69. PubMed ID: 10364076
[TBL] [Abstract][Full Text] [Related]
13. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates.
Vu-Dac N; Chopin-Delannoy S; Gervois P; Bonnelye E; Martin G; Fruchart JC; Laudet V; Staels B
J Biol Chem; 1998 Oct; 273(40):25713-20. PubMed ID: 9748239
[TBL] [Abstract][Full Text] [Related]
14. Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells.
Clavey V; Copin C; Mariotte MC; Baugé E; Chinetti G; Fruchart J; Fruchart JC; Dallongeville J; Staels B
Cell Physiol Biochem; 1999; 9(3):139-49. PubMed ID: 10494028
[TBL] [Abstract][Full Text] [Related]
15. Regulation of aldehyde reductase expression by STAF and CHOP.
Barski OA; Papusha VZ; Kunkel GR; Gabbay KH
Genomics; 2004 Jan; 83(1):119-29. PubMed ID: 14667815
[TBL] [Abstract][Full Text] [Related]
16. A novel compound 4010B-30 upregulates apolipoprotein A-I gene expression through activation of PPARγ in HepG2 cells.
Du Y; Wang L; Si S; Yang Y; Hong B
Atherosclerosis; 2015 Apr; 239(2):589-98. PubMed ID: 25734982
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Smads in TGFbeta1-induced furin (fur) transcription.
Blanchette F; Rudd P; Grondin F; Attisano L; Dubois CM
J Cell Physiol; 2001 Aug; 188(2):264-73. PubMed ID: 11424093
[TBL] [Abstract][Full Text] [Related]
18. The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers.
Vergnes L; Taniguchi T; Omori K; Zakin MM; Ochoa A
Biochim Biophys Acta; 1997 Oct; 1348(3):299-310. PubMed ID: 9366246
[TBL] [Abstract][Full Text] [Related]
19. DNA binding specificity and transactivation properties of SREBP-2 bound to multiple sites on the human apoA-II promoter.
Kan HY; Pissios P; Chambaz J; Zannis VI
Nucleic Acids Res; 1999 Feb; 27(4):1104-17. PubMed ID: 9927745
[TBL] [Abstract][Full Text] [Related]
20. Increase in hepatic expression of SREBP-2 by gemfibrozil administration to rats.
Roglans N; Peris C; Verd JC; Alegret M; Vázquez M; Sánchez RM; Laguna JC
Biochem Pharmacol; 2001 Sep; 62(6):803-9. PubMed ID: 11551527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
